Skip to main content

Validea's pick of the week provides a detailed report on a company that scores well in the stock-screening service's model portfolios. On Validea.ca, investors can analyze 1,000 Canadian stocks through 12 different guru-based models and get individual reports on each company. Globe Investor provides marketing and data services to Validea.ca and receives compensation. Try it.

Greenbrier Companies (GBX) is a transportation manufacturing company. According to the $1-billion firm's web site, it is a "leading international supplier of equipment and services to the freight rail transportation markets."

The stock gets high marks based on Validea's Price / Sale Investor strategy, which is based on the book Super Stocks, written by Kenneth Fisher. The Price / Sales model is a value strategy that rewards stocks with low price / sale ratios, long-term profit growth, strong free cash flow and consistent profit margins.

Story continues below advertisement

GBX's price / sales ratio of 0.38, based on trailing 12-month sales, is below 0.75, which is considered quite attractive in this model. The P/E of 6.3 and P/B of 1.2 also make the shares attractive from a valuation perspective.

Less debt equals less risk, according to this methodology, and GBX's debt/equity of 34.77 per cent is acceptable.

GBX generates free cash per share of $5.22, which is a positive, while its 3-year net profit margin of 6.44 per cent is about the threshold of 5 per cent.

The stock's dividend yield of 2.3 per cent adds to its attractiveness.

Click here for a complete breakdown of Validea's investing guru report.

Globe app users click here.

Read other research reports here.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter